Jian Cao

机构：Tracon Pharmaceuticals (United States) · ORCID：0000-0001-7934-5025

发表论文 61 篇 · 总被引 777 次 · h-index 14

代表论文

NAD+ supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells (2021 · Cell Reports · 被引 119)
A New Risk Index Combining d -Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer From Patients With Abnormal Vaginal Bleeding or Discharge (2020 · Technology in Cancer Research & Treatment · 被引 30)
Comparison of Renal Artery vs Renal Artery-Vein Clamping During Partial Nephrectomy: A System Review and Meta-Analysis (2020 · Journal of Endourology · 被引 23)
C1222C Deletion in Exon 8 of ABL1 Is Involved in Carcinogenesis and Cell Cycle Control of Colorectal Cancer Through IRS1/PI3K/Akt Pathway (2020 · Frontiers in Oncology · 被引 20)
Progress in Applicability of Scoring Systems Based on Nutritional and Inflammatory Parameters for Ovarian Cancer (2022 · Frontiers in Nutrition · 被引 16)
<p>Modified Usage of Negative Pressure Wound Therapy for the Management of Severe Deep Fascial Space Infections in the Head and Neck</p> (2020 · Infection and Drug Resistance · 被引 14)